| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/22/2004 | EP1261335A4 Brain, spinal and nerve injury treatment |
| 09/22/2004 | EP1228056B1 Method for the preparation of citalopram |
| 09/22/2004 | EP1224206B1 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1157989B1 Fluorides of 4-substituted piperidine derivatives |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1141251A4 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 09/22/2004 | EP1140981B1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 09/22/2004 | EP1140860B1 Pyrimidine compounds |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1100781B1 High affinity ligands for nociceptin receptor orl-1 |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1077950B1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP0984786B1 Use of low-molecular-weight heparins for preventing and treating central nervous system trauma |
| 09/22/2004 | EP0914119B1 Process for forming solid oral dosage forms of valsartan |
| 09/22/2004 | EP0830347B1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 09/22/2004 | EP0706524B1 Processes and intermediates for the preparation of 5- 2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531592A Process for preparation of neutrophil inhibitory factor |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531537A Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
| 09/22/2004 | CN1531432A New use of iloperidone |
| 09/22/2004 | CN1531431A Prevention of addiction in pain management |
| 09/22/2004 | CN1531428A Novel pharmaceutical composition for administering N-0923 |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1531420A Pharmaceutical formulation for efficient administration of apomorphine, 6aR-(-)-N-propyl-norepomorphine and their derivatives and pro-drugs thereof |
| 09/22/2004 | CN1530363A Method of extracting terpene lactone from folium ginkgo leaves and product |
| 09/22/2004 | CN1530121A Preparation of manyprickle acanthopanax capsules |
| 09/22/2004 | CN1530110A Naloxone freeze-drying powder injection and preparing technology thereof |
| 09/22/2004 | CN1530107A Insulin resistance treatment by growth hormone secretory hormone |
| 09/22/2004 | CN1530103A Health article for ensuring normal sleep |
| 09/22/2004 | CN1530102A Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases |
| 09/22/2004 | CN1167707C 2,3-O-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 09/22/2004 | CN1167703C Azabicyclic carbamates and their use as alpha-7 nicotinic acetyl choline receptor agonists |
| 09/22/2004 | CN1167698C New N-triazolyl methyl piperazine derivative using as neurokinin receptor antagonistic agent |
| 09/22/2004 | CN1167694C 1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167686C Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds |
| 09/22/2004 | CN1167682C Muscarinic antagonists |
| 09/22/2004 | CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands |
| 09/22/2004 | CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d |
| 09/22/2004 | CN1167463C Preparation of medicines for diseases in peripheral nerve system and male genetic defects |
| 09/22/2004 | CN1167444C Psychosis treating capsules |
| 09/22/2004 | CN1167438C Capsules for tonifying kidney and tranquilization and their preparation |
| 09/22/2004 | CN1167427C Preparing method of life prolonging preparation |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794500 RNA-binding protein |
| 09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 09/21/2004 | US6794405 Alicyclic imidazoles as H3 agents |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794389 Quinazoline derivatives and drugs |
| 09/21/2004 | US6794388 Succinic acid salts of 5,7,14-triazatetracyclo[10.3.1.02,11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters |
| 09/21/2004 | US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders |
| 09/21/2004 | US6793936 Delivers an active ingredient in a pulsed or bimodal manner. |
| 09/21/2004 | CA2420184C Conotoxins |
| 09/21/2004 | CA2191871C Piperazine derivatives as 5ht1a antagonists |
| 09/21/2004 | CA2150131C Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity |
| 09/21/2004 | CA2100381C N-derivatives of (phenylethyl-.beta.-ol) amine, a process for their preparation and pharmaceutical compositions containing the same |
| 09/17/2004 | CA2457989A1 The use of vitamin b6 to mitigate visual field defects associated with the use of gabaergic drugs in mammals |
| 09/16/2004 | WO2004078908A2 Alpha-keto carbonyl calpain inhibitors |
| 09/16/2004 | WO2004078760A1 SUBSTITUTED 8'-PYRIDINYL-DIHYDROSPIRO-[CYCLOALKYL]-PYRIMIDO [1,2-a] PYRIMIDIN-6-ONE AND 8'-PYRIMIDINYL-DIHYDROSPIRO-[CYCLOALKYL]-PYRIMIDO [1,2-a] PYRIMIDIN-6-ONE DERIVATIVES AND THEIR USE AGAINST NEUROGENERATIVE DISEASES |
| 09/16/2004 | WO2004078759A1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 09/16/2004 | WO2004078756A2 Jnk inhibitors |
| 09/16/2004 | WO2004078750A1 Tetrahydropyran compounds as tachykinin antagonists |
| 09/16/2004 | WO2004078728A1 NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS |
| 09/16/2004 | WO2004078719A1 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 09/16/2004 | WO2004078715A1 Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl |
| 09/16/2004 | WO2004078208A1 MEDICINAL USE OF MIP-3α INHIBITOR AND METHOD OF SCREENING BRAIN/NERVE CELL PROTECTIVE AGENT |
| 09/16/2004 | WO2004078200A1 Selection of patients with increased responsiveness to botulinum toxin |
| 09/16/2004 | WO2004078189A1 Use of rutin and isoharmnetin for treating depressive states and depression and other emotion disorders |
| 09/16/2004 | WO2004078184A1 Use of adenosine receptor agonists in therapy |
| 09/16/2004 | WO2004078180A2 Naaladase inhibitors for treating opioid tolerance |
| 09/16/2004 | WO2004078177A1 Remedy for drug/substance dependence |
| 09/16/2004 | WO2004078176A1 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators |
| 09/16/2004 | WO2004078173A1 Tablet having improved dissolution characteristics |
| 09/16/2004 | WO2004078162A1 Nanoparticulate topiramate formulations |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004058152A3 An extended release pharmaceutical composition of phenytoin sodium |
| 09/16/2004 | WO2004047837A3 Beta-blockers having antioxidant and nitric oxide-donor activity |
| 09/16/2004 | WO2004033652A3 Inhibitors of fatty acid amide hydrolase |
| 09/16/2004 | WO2003104253A3 9-alpha-substituted estratrienes as selectively active estrogen |
| 09/16/2004 | WO2003066004A3 Therapeutic compounds |
| 09/16/2004 | WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |